RARX

Ra Pharmaceuticals, Inc. Common Stock
RARX

Overview Fund Activity
Delisted

RARX was delisted on the 1st of April, 2020.

Back to rankings

144 hedge funds and large institutions have $2.47B invested in Ra Pharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 47 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
144
Holders Change
-2
Holders Change %
-1.37%
% of All Funds
3.18%
Holding in Top 10
11
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+120%
% of All Funds
0.24%
New
34
Increased
49
Reduced
47
Closed
33
Calls
$3.53M
Puts
$30.7M
Net Calls
-$27.2M
Net Calls Change
-$9.47M

Top Buyers

1
HI
1
HBK Investments
Texas
$96.2M
2
WCMNY
2
Westchester Capital Management (New York)
New York
$60.8M
3
Barclays
3
Barclays
United Kingdom
$52.7M
4
PCM
4
Pentwater Capital Management
Florida
$47M
5
TAL
5
TIG Advisors LLC
New York
$37.4M

Top Sellers

1
DM
1
Deerfield Management
New York
$0
2
Citigroup
2
Citigroup
New York
$36.2M
3
Citadel Advisors
3
Citadel Advisors
Florida
$2.06M
4
RSCM
4
Rock Springs Capital Management
Maryland
$0
5
AA
5
AQR Arbitrage
Connecticut
$57.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
OPS
176
Orion Portfolio Solutions
Nebraska
– -$1K -17 Closed
4 5 6 7
8